Viewing Study NCT03300557

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:06 PM
Ignite Modification Date: 2026-01-22 @ 11:40 AM
Study NCT ID: NCT03300557
Status: COMPLETED
Last Update Posted: 2025-08-29
First Post: 2017-10-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atypical Hyperplasia View
None Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia View
None Endometrial Carcinoma View
None FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma View
None FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma View
Keywords: